Ignite Creation Date:
2024-05-06 @ 6:11 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05578053
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-10-13
First Post:
2022-10-10
Brief Title:
Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Hebei Medical University Fourth Hospital
Organization Data
Organization:
Hebei Medical University Fourth Hospital
Class:
OTHER
Study ID:
2022106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hebei Medical University Fourth Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Cuizhi GENG
Responsible Party Title:
Vice President of Hebei Medical University Fourth Hospital
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Hebei Medical University Fourth Hospital
Old Name:
None
Old Organization:
None